Literature DB >> 7412870

Human cell-surface glycoprotein with unusual properties.

M B Omary, I S Trowbridge, J Minowada.   

Abstract

We report here the identification of human cell-surface glycoprotein with unusual and interesting properties. We initially detected this glycoprotein on the surface of cultured human haematopoietic cell lines by means of a monoclonal antibody. Although it is expressed on all cultured human haematopoietic cell lines tested, including the inducible promyelocytic tumour cell line HL-60 (ref. 1), it is not present in readily detectable amounts on most normal or leukaemic human haematopoietic cells. HL-60 cells, on exposure in vitro to appropriate chemical inducers, undergo morphological and functional differentiation along the granulocytic pathway or into macrophage-like cells. One consequence of in vitro induction in the specific loss of the glycoprotein from the surface of HL-60 cells. The molecule does not, however, seem to be a highly tissue-specific differentiation antigen because it is also found on human tumour cell lines derived from non-haematopoietic tissues. Rather, its expression seems to be related to cell proliferation. Preliminary chemical characterization suggests that the glycoprotein maybe identical to the abnormal glycoprotein previously reported by Bramwell and Harris to be associated with malignancy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7412870     DOI: 10.1038/286888a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles.

Authors:  K K Pohaku Mitchell; S Sandoval; M J Cortes-Mateos; J G Alfaro; A C Kummel; W C Trogler
Journal:  J Mater Chem B       Date:  2014-12-07       Impact factor: 6.331

3.  Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.

Authors:  Brian M Barth; Rahul Sharma; Erhan I Altinoğlu; Thomas T Morgan; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Gail L Matters; Jill P Smith; Mark Kester; James H Adair
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

Review 4.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

5.  p180, a novel recycling transmembrane glycoprotein with restricted cell type expression.

Authors:  C M Isacke; P van der Geer; T Hunter; I S Trowbridge
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

7.  Deletional analysis of the promoter region of the human transferrin receptor gene.

Authors:  J L Casey; B Di Jeso; K K Rao; T A Rouault; R D Klausner; J B Harford
Journal:  Nucleic Acids Res       Date:  1988-01-25       Impact factor: 16.971

8.  Fetal and neonatal development of human spleen: an immunohistological study.

Authors:  W Timens; T Rozeboom; S Poppema
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

Review 9.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

10.  Biological effects of antibodies to lymphocyte surface receptors.

Authors:  J W Goding
Journal:  Springer Semin Immunopathol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.